IBSP and lung carcinoma: Treating lung cancer cells with BSP inhibited the protein and mRNA expression of E‐cadherin and promoted vimentin expression (Figure 1E–H), whereas inhibiting BSP expression had the opposite effects (Figure 1J–L).